Peter Radovich
President chez MIRUM PHARMACEUTICALS, INC.
Fortune : 728 807 $ au 31/03/2024
Provenance du réseau au premier degré de Peter Radovich
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.
34
| Extinct | Medical Specialties | 34 |
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Public Company | Pharmaceuticals: Major | 24 | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.
20
| Subsidiary | Pharmaceuticals: Major | 20 |
| Subsidiary | Biotechnology | 14 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Radovich via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Treasurer Corporate Officer/Principal | |
| CELGENE | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer General Counsel Director/Board Member Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chief Operating Officer Chairman Chief Tech/Sci/R&D Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | President Director/Board Member Sales & Marketing | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Investor Relations Contact | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Investor Relations Contact Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Haas School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member Founder Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member Investor Relations Contact | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Compliance Officer Corporate Officer/Principal | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| TARSUS PHARMACEUTICALS, INC. | Director/Board Member Director of Finance/CFO Director/Board Member | ||
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Director of Finance/CFO | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Founder Private Equity Investor | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member Director/Board Member | |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 46 |
| Royaume-Uni | 4 |
| Irlande | 2 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Health Services | 2 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 563 |
| Corporate Officer/Principal | 261 |
| Independent Dir/Board Member | 215 |
| Chief Tech/Sci/R&D Officer | 86 |
| Undergraduate Degree | 84 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Patrick Heron | 42 |
| Franklin Berger | 41 |
| Timothy Walbert | 40 |
| Michael Grey | 32 |
| Michael Bonney | 32 |
| Thomas Wiggans | 31 |
| David Lawrence | 29 |
| Nicole Vitullo | 28 |
| Charles Homcy | 28 |
| Deval Patrick | 28 |
| Laura Brege | 27 |
| Tiba Aynechi | 24 |
| Carol Brosgart | 24 |
| Hans Bishop | 24 |
- Bourse
- Insiders
- Peter Radovich
- Connexions Sociétés
